ASX: ALA Arovella Therapeutics Limited ACN 090 987 250 Corporate One, 84 Hotham Street, Preston, VIC 3072 Australia Telephone: + 61 3 9863 6472 investor@arovella.com | www.arovella.com ASX Release 7 October 2026 SECOND CLINICAL BATCH RELEASED FOR IMMEDIATE PATIENT USE Highlights: • A...
Second Clinical Batch Released for Immediate Patient Use
Earlier from Arovella Therapeutics
- The path to first patient dosing
- Clinical manufacturing batch released, first site activated
- Arovella Appoints Acting CEO
- Board Refresh and CEO Resignation
